Biologicals for cancer treatment: Growth and differentiating agents Journal Article


Author: Moore, M. A. S.
Article Title: Biologicals for cancer treatment: Growth and differentiating agents
Abstract: Studies of agents that 'kill' tumor cells, by making them differentiate or by otherwise inhibiting their proliferation, are yielding some promising clinical leads, especially for the treatment of myeloid leukemia. Two broad types of physiologic agents have such activity: analogues of vitamins A and D and endogenous cytokines that can be isolated from stimulated cells.
Keywords: cancer chemotherapy; interferon; cancer combination chemotherapy; cytarabine; cancer immunotherapy; dexamethasone; cell differentiation; calcitriol; cancer therapy; dimethyl sulfoxide; gamma interferon; drug mechanism; vitamin d; dactinomycin; short survey; isotretinoin; retinol; retinoic acid; therapy; growth inhibition; phorbol 13 acetate 12 myristate; survey; myeloid leukemia; colecalciferol; cell strain hl 60; hexamethylenebisacetamide; n,n dimethylformamide; human; priority journal; biological response; blood and hemopoietic system
Journal Title: Hospital Practice
Volume: 21
Issue: 2
ISSN: 2154-8331
Publisher: Taylor & Francis Group  
Date Published: 1986-02-15
Start Page: 69
End Page: 80
Language: English
DOI: 10.1080/21548331.1986.11706569
PUBMED: 3081537
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 18 August 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Malcolm A S Moore
    549 Moore